IP Library › Granted Patent US 9,987,323
Granted Patent B2
US 9,987,323 · App. 15/444,669 · Granted Jun 5, 2018

Process to enhance the bioactivity of Ashwagandha extracts

Inventor: Benny Antony (Angamaly, IN)
A61K36/81A61K9/14A61K36/185A61K36/23A61K36/47A61K36/48A61K36/53A61K36/534A61K36/54A61K36/67A61K36/71A61K36/82A61K36/87A61K36/9066A61K36/9068
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,987,323
App. No.
15/444,669
Granted
Jun 5, 2018
Kind
B2
Abstract

The invention relates to an extract of Ashwagandha that exhibit enhanced bioactivity and bioavailability comprising of enriched withanolide glycosides and saponins; with negligible amount of alkaloids, withanolide aglycones and oligosaccharides. The extract as disclosed prepared from root, stems, leaves and whole plant of Ashwagandha further shows improved immunomodulatory activity, anti-inflammatory activity, anti stress activity, antidiabetic activity and sleep quality. The disclosure also provides a method of improving bioactivity of withanolide glycosides even at lower doses, by the administration of an enteric coated formulation of extract of Ashwagandha to humans. The enteric coating protects the composition from hydrolysis in the acidic environment of the stomach to release the withanolide glycoside in neutral/alkaline pH in gastrointestinal tract (GIT) thus enhancing the absorption. Further the process of preparation of the extract of Ashwagandha enriched with withanolide glycosides and saponins are disclosed along with various formulations.

Claims (62)

1. An enteric coated composition comprising an extract of Withania somnifera and an enteric coating material, wherein the extract of Withania somnifera comprises by weight:

at least about 3.5% withanolide glycosides,

less than about 0.1% withanolide aglycones, and,

less than about 0.1% alkaloids, and,

less than about 0.1% oligosaccharides, and,

wherein the enteric coating material is selected from the group consisting of poly (methacrylic acid-co-methyl methacrylate), and, a combination of modified ethyl cellulose and sodium alginate.

2. The enteric coated composition of claim 1 , wherein the extract of Withania somnifera comprises at least about 35% withanolide glycosides by weight.

3. The enteric coated composition of claim 1 , wherein the extract of Withania somnifera comprises at least about 80% withanolide glycosides by weight.

4. The enteric coated composition of claim 1 , further comprising by weight: at least about 0.1% saponins.

5. The enteric coated composition of claim 1 , further comprising by weight: about 2.5% saponins.

6. The enteric coated composition of claim 1 , further comprising by weight:

about 10% saponins.

7. The enteric coated composition of claim 1 , further comprising by weight:

about 15% saponins, and,

and wherein the withanolide glycosides comprised sitoindoside I to X, withanoside I to VII and withanamides.

8. An enteric coated composition comprising:

(1) the enteric coated composition of the extract of Withania somnifera of claim 1 , and

(2) a second extract,

wherein the second extract selected from the group consisting of amla extract, turmeric extract, grape seed extract, green tea extract, pomegranate extract, Amaranth extract, costus extract, cocoa extract, coconut root extract, rosemary extract, mint leaf extract, star anise, sweet basil extract, cinnamon extract/clove extract, ginger extract, cumin seed extract, black pepper extract, fenugreek extract, nitrate-rich vegetables and combinations thereof.

9. An enteric coated composition comprising a combination coated with an enteric coating material, wherein the combination comprises:

1) an extract Withania somnifera , and,

2) a second extract selected from the group consisting of amla extract, turmeric extract, grape seed extract, green tea extract, pomegranate extract, Amaranth extract, costus extract, cocoa extract, coconut root extract, rosemary extract, mint leaf extract, star anise, sweet basil extract, cinnamon extract/clove extract, ginger extract, cumin seed extract, black pepper extract, fenugreek extract, nitrate-rich vegetables and combinations thereof,

wherein the extract of Withania somnifera comprises by weight:

at least about 3.5% withanolide glycosides,

less than about 0.1% alkaloids,

less than about 0.1% withanolide aglycones, and,

less than about 0.1% oligosaccharides, and,

wherein the enteric coating material is selected from the group consisting of poly (methacrylic acid-co-methyl methacrylate), and, a combination of modified ethyl cellulose and sodium alginate.

10. An enteric coated composition of an extract of Withania somnifera comprising an extract of Withania somnifera and an enteric coating material,

wherein the extract of Withania somnifera comprises by weight:

at least about 3.5% withanolide glycosides,

no more than about 0.1% withanolide aglycones, and,

no more than about 0.1% alkaloids,

less than about 0.1% oligosaccharides,

wherein the extract of Withania somnifera is prepared by a method comprising:

a) treating cleaned fresh roots of Withania somnifera with ammonia;

b) extracting the product of step a) with methylene dichloride to obtain a filterate and a residue;

c) washing the residue of step b) with water to obtain a wash having a pH ranging from about 6 to about 7, and, a washed residue;

d) drying the washed residue of step c) at about 90 to about 100° C. to obtain a dried residue;

e) powdering the dried residue of step d) to obtain a first extract of roots of Withania somnifera , wherein the first extract of roots of Withania somnifera of step e) is a powder,

f) extracting the first extract of Withania somnifera of step e) with methanol at about 60° C. to about 70° C. to obtain a supernatant and a residue;

g) concentrating the supernatant of step f) to obtain a concentrate;

h) drying the concentrate of step g) to obtain a first dried methanol extract, wherein the first dried methanol extract of step h) is a powder,

i) dissolving the first dried methanol extract of step h) in water;

j) clarifying the product of step i) to obtain a supernatant and a residue;

k) loading the supernatant of step j) onto an adsorbing column;

l) eluting the adsorbing column of step k) with water and then with 50% methanol;

m) concentrating and drying the 50% methanol elute to obtain a second dried methanol extract of roots of Withania somnifera , wherein the second dried methanol extract of step m) is a powder,

n) dissolving the second dried methanol extract of step m) in water;

o) centrifuging the product of step n) to obtain a supernatant and a residue;

p) loading the supernatant of step o) onto an adsorbing column;

q) eluting the adsorbing column of step p) with 10% methanol;

r) eluting the adsorbing column of step q) with 50% methanol to obtain a 50% methanol eluate;

s) dissolving the 50% methanol eluate of step r) in methanol;

t) concentrating the product of step s);

u) adding acetone to the product of step t) to obtain a precipitate;

v) filtering and drying the precipitate of step u) to obtain a powder of a third extract of roots of Withania somnifera,

wherein the extract of Withania somnifera is selected from the group consisting of the second dried methanol extract of step m), the third extract of roots of Withania somnifera of step v), and combinations thereof,

wherein the enteric coated composition of the extract of Withania somnifera is prepared by a method comprising:

preparing granules of the extract of Withania somnifera , and,

spraying the granules with an enteric coating material to obtain the enteric coated composition, and,

wherein the enteric coating material is selected from the group consisting of poly (methacrylic acid-co-methyl methacrylate), and, a combination of modified ethyl cellulose and sodium alginate.

Priority Claims (1)
IN 5691/CHE/2015 · Oct 22, 2015 · national
Continuity (2)
Continuation 15326450
Related Publication 20170173100A1 · Jun 22, 2017